DRIVERS IN HTA DECISION-MAKING FOR CHOLESTEROL LOWERING PCSK9 INHIBITORS

被引：0
|
作者：
Kreeftmeijer, J. [1 ]
Dekkers, R. [1 ]
van Engen, A. [1 ]
机构：
[1] Quintiles Advisory Serv, Hoofddorp, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1474
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY157
引用
收藏
页码：A603 / A603
页数：1
相关论文
共 50 条
  • [21] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [22] PCSK9 inhibitors
    Farnier, Michel
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
  • [23] PCSK9 inhibitors
    Gencer, Baris
    Lambert, Gilles
    Mach, Francois
    SWISS MEDICAL WEEKLY, 2015, 145
  • [24] PCSK9 inhibition: a new player in cholesterol-lowering therapies?
    David Preiss
    Colin Baigent
    Nature Reviews Nephrology, 2017, 13 : 450 - 451
  • [25] PCSK9 inhibition: a new player in cholesterol-lowering therapies?
    Preiss, David
    Baigent, Colin
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (08) : 451 - 452
  • [26] Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book
    Santos, Raul D.
    Rocha, Viviane Z.
    EUROPEAN HEART JOURNAL, 2023, 44 (02) : 139 - 141
  • [27] PCSK9, a novel target for lowering LDL cholesterol: promise and progress
    Tavori, Hagai
    Fazio, Sergio
    Linton, MacRae F.
    CLINICAL LIPIDOLOGY, 2012, 7 (06) : 611 - 615
  • [28] PCSK9 Inhibitors The Magic Bullet for LDL Cholesterol Reduction?
    Richter, Kurt
    Barthel, Andreas
    Bornstein, Stefan R.
    El-Armouche, Ali
    Wagner, Michael
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (12) : 863 - U181
  • [29] Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
    Safarova, Maya
    Bimal, Tia
    Soffer, Daniel E.
    Hirsh, Benjamin
    Shapiro, Michael D.
    Mintz, Guy
    Cha, Agnes
    Gianos, Eugenia
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 19
  • [30] LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
    Sabatel-Perez, F.
    Garcia-Ropero, A.
    Santos-Gallego, G.
    Zafar, M. Urooj
    Badimon, J. J.
    DRUGS OF TODAY, 2019, 55 (05) : 329 - 344
12345